Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers

Clinical trial NCT01291524 · COMPLETED

Trial details

NCT number

NCT01291524

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-02-01

Primary completion

2011-05-01

Enrollment

24

View on ClinicalTrials.gov